Treace Announces Participation in Two Upcoming Investor Conferences

Core Insights - Treace Medical Concepts, Inc. is participating in upcoming investor conferences, highlighting its engagement with the investment community [1][6] - The company focuses on advancing surgical treatments for bunions and related midfoot deformities, addressing a significant market need [4] Company Overview - Treace Medical Concepts is a medical technology company aiming to improve the standard of care for bunion surgeries, which affect approximately 65 million Americans, with an estimated 1.1 million being surgical candidates annually [4] - The company has developed the patented Lapiplasty 3D Bunion Correction System, which addresses the root cause of bunions by correcting deformities in three planes and stabilizing the affected joint [4] - Treace has introduced additional systems such as the Adductoplasty Midfoot Correction System and SpeedMTP™ Rapid Compression Implant, expanding its offerings for various bunion and midfoot deformities [4] Upcoming Events - Treace will participate in the UBS Global Healthcare Conference on November 10, 2025, and the Stifel 2025 Healthcare Conference on November 11, 2025, indicating its proactive approach to investor relations [6]